A comprehensive view of hospital / clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca plans to introduce 20 new medicines by 2030, focusing on cancer care and rare diseases; the company targets 75% growth in annual revenues by 2030

Eli Lilly reports more than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure

Sanofi, Formation Bio, and OpenAI collaborate on first-in-class AI-powered software for accelerating drug development; teams will bring together data, software, and tuned models

Physicians received US$12.1B in payments from drug and device makers through Dec. 2022, with 57% of eligible physicians receiving at least one payment; orthopedic surgeons received the most at US$1.36B: Assn. of Health Care Journalists

Forty-eight pharma M&A deals worth €33.55B took place in Q1 2024; Novo Holdings led the top five acquisitions, with a €10.659B deal for Catalent followed by Gilead's €3.95B deal for CymaBay Therapeutics: Evaluate Pharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count